LONDON, March 21, 2017 /PRNewswire/ -- The global ADME/TOX market is largely driven by the efforts of pharmaceutical
This June, SMi will be presenting the 4th annual ADMET conference and exhibition in London, featuring industry specialist, discussing ADME/Tox profiling of a drug candidate and how it plays a crucial role in reducing clinical trials cost and time of drug launch to the market.
The 2017 conference agenda has been produced to offer delegates unparalleled networking opportunities, greater insight into the ADMET industry, and spotlight sessions on drug discovery strategies and PBPK modelling. Featured session not be missed will include:
Understanding PK/PD during drug discoveryRobert van Waterschoot, Head of Pharmacokinetics, Dynamics & Metabolism (PDM) Leaders, RocheIn this session Robert will explore which parameters determine the efficacious dose, whilst revisiting the free drug hypothesis.
PBPK modelling – Pragmatic application in drug developmentJackie Bloomer, Director, GSKJackie will be discussing case histories from GSK which illustrate how bespoke application of PBPK modelling can influence decision making throughout drug development.
Estimation of human volume of distribution; methods, accuracy and impact in human dose predictionCarl Petersson, Associate Director Drug Disposition, Merck KGaACarl will explore the Impact of preclinical species used for extrapolation and method comparison of accuracy and statistical significance of differences.
Drug-Drug Interactions Involving Transporters – Theory and PracticeMatthias Wittwer, Laboratory Head DMPK-BANP-NCPK, BayerMatthias will deliver a short synopsis on drug-drug interactions involving transporters with interesting examples from literature and supporting Bayer case-examples.
Delegates will also be afforded the opportunity to truly maximise their potential by attending the post-conference interactive workshop on Wednesday 14th June 2017. This additional session has been carefully structured to provide delegates with additional hands on training whilst complementing the topics of discussion covered throughout the conference.
Drug Transporter Tool KitWednesday 14th June 2017 | 08.30am - 12.30pmHosted by: Kunal Taskar, Associate GSK Fellow, GSK
For the complete 2 day agenda, visit the event website: www.admet-event.com/prlog
There is currently a £200 early bird discount for all bookings made before 31st March 2017. For more information visit www.admet-event.com/prlog
12th ADMET 201712th – 13th June 2017London, UKwww.admet-event.com/prlog
Follow the conversation on Twitter and LinkedIn at #smiADMET17
Press release distributed by PRLog
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pbpk-pkpd-ddi-transporters-and-human-dose-prediction-explained-by-novartis-roche-merck-kgaa-and-gsk-300427052.html
SOURCE SMi Group
Subscribe to our Free Newsletters!
This cancer affects men over the age of 50 years and screening with rectal examination and PSA can ...
Hyperacusis is a chronic hearing disorder characterized by an abnormal sensitivity to s ...
Proton beam therapy is a type of external radiation treatment or radiotherapy that uses protons ...View All